A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD6714 in Healthy Male Volunteers and Male Type II Diabetic Patients.
Phase of Trial: Phase I
Latest Information Update: 06 Dec 2010
At a glance
- Drugs AZD 6714 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 06 Dec 2010 Planned end date changed from 1 Dec 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
- 30 Oct 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.